About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The research group is composed by clinical researchers (pediatric surgeons, traumatologists, neonatologists and obstetricians) and basic researchers (biochemists, biotechnologists and biologists). Our multidisciplinary team has an extensive expertise in the field of biomedical research and a strong translational spirit to the human clinic. The main objectives of our research are addressed to:
In addition, our research team has extensive experience in the field of regenerative medicine and nanomedicine especially focused on the development of new therapeutic strategies for the treatment of musculoskeletal and osteoarticular pathologies and we are currently participating in highly innovative projects both at national and international level.
IP: Manuel López Paredes Collaborators: José Andrés Molino Gahete, Ana Lain Fernandez, María Díaz Hervás, José Luis Peiró Ibáñez, Laura Vidal Fornells, Carlos Giné Prades, Gloria Fatou Royo Gomes, Francisco Soldado Carrera, Mario Marotta Baleriola, Sergio Lopez Fernandez, Romy Gander, Rodrigo Maluje Juri Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 01240 Duration: 01/01/2022 - 30/06/2025
IP: Nerea Maiz Elizaran Collaborators: Ana Lain Fernandez, Margarita Codinach Creus, Silvia Arévalo Martínez, Pablo García Manau, Paula Garcia Aguilar, Susana Manrique Muñoz, Manuel López Paredes, Ester Del Barco Martínez, Erika Bonacina Funding agency: Instituto de Salud Carlos III Funding: 135520 Reference: PI20/00421 Duration: 01/01/2021 - 30/06/2025
IP: Maria Jose Soler Romeo Collaborators: Mario Alonso Narvaez Barros, Pamela Dominguez Baez, Sheila Bermejo Garcia, Alejandra Planas Vilaseca, Concepció Jacobs Cachá, Juan Carlos León Román, Irene Martinez Diaz Funding agency: Instituto de Salud Carlos III Funding: 122210 Reference: PI21/01292 Duration: 01/01/2022 - 30/06/2026
Divuit hores de programa solidari recull més de 8 milions d'euros per lluitar contra les malalties del cor. A Catalunya, una de cada quatre persones moren a causa d'una malaltia del cor o un ictus
